Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health
5h ago
From the article
NEWYou can now listen to Fox News articles! GLP-1 weight-loss drugs have become a prevalent part of American healthcare, and the current administration is getting behind the movement. In an exclusive interview with Fox News Digital at the Great American State Fair in Washington D.C. on July 6, CMS Administrator Dr. Mehmet Oz voiced his […]
Continue reading on NEW YORK TIMESYou might also wanna read
Dr Oz links obesity to chronic disease surge, says GLP-1s can 'jumpstart' better health
foxnews.com·5h ago
GLP-1 Prescriptions Rise as U.S. Obesity Rates Show Modest Decline, New Data Indicates
New data from EPIC Research shows that GLP-1 medications like Ozempic and Wegovy are having a population-wide impact on obesity rates. As pr
gizmodo.com·1mo ago
Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows
This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p
theverge.com·1mo ago
GLP-1 Drug Use Triples In Two Years As American Obesity Rate Falls, Gallup Finds
Foreign Policy Journal·5h ago
Experts warn easy access to GLP-1 drugs may increase eating disorder risks
Experts are raising concerns that the widespread availability of GLP-1 drugs (like Ozempic and Wegovy) through telemedicine and oral formula
mdsc.pe·19d ago
ADA 2026 Scientific Sessions: New GLP-1 Drugs and Diabetes Research Highlights
In this JAMA Medical News podcast, Jennifer Abbasi interviews Dr. Rita Kalyani, the ADA's Chief Scientific and Medical Officer, about key hi
ja.ma·19d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.